Injection/Infusion
DEPO MEDROL WITH LIDOCAINE INJ
Summary
DEPO MEDROL WITH LIDOCAINE INJ — Injection/Infusion containing lignocaine hydrochloride, methylprednisolone acetate. Hong Kong Registration No. HK-00437. Certificate Holder: PFIZER CORPORATION HONG KONG LIMITED. Date of Registration: 15 Aug, 1978.
Product NameDEPO MEDROL WITH LIDOCAINE INJ
Registration No.HK-00437
Certificate HolderPFIZER CORPORATION HONG KONG LIMITED
Holder Address21/F, KERRY CENTRE, 683, KING'S ROAD, QUARRY BAY, HONG KONG
Ingredientslignocaine hydrochloride, methylprednisolone acetate
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration15 Aug, 1978
ATC codesC01BB01, C05AD01, D04AB01, D07AA01, D10AA02, H02AB04, N01BB02, R02AD02, S01HA07, S02DA01
ATC Classification
ATC level 1
C Cardiovascular System / D Dermatologicals / H Systemic Hormonal Preparations / N Nervous System / R Respiratory System / S Sensory Organs
All ATC groupsC01, C05, D04, D07, D10, H02, N01, R02, S01, S02
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。